SCHEMBL4013121

SCHEMBL4013121

COC(=O)C(O)(CC1OCCO1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.49
SRC P12931 1/20 0.41
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
KMT2A Q03164 1/20 0.38
NPY2R P49146 2/20 0.38
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
POLB P06746 1/20 0.37
CHRM3 P20309 1/20 0.37
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21656187 0.77 KCNN4 (0.58) KCNN4SRCMEN1OPRM1OPRD1
SCHEMBL11228441 0.75 KCNN4 (0.60) KCNN4SRCALDH1A1MEN1OPRM1
SCHEMBL4166704 0.75 KCNN4 (0.60) KCNN4SRCMEN1OPRM1OPRD1
SCHEMBL4014494 0.75 KCNN4 (0.60) KCNN4SRCALDH1A1MEN1OPRM1
SCHEMBL4012323 0.74 KCNN4 (0.58) KCNN4SRCMEN1OPRM1OPRD1
SCHEMBL7959301 0.74 KCNN4 (0.58) KCNN4SRCMEN1OPRM1OPRD1
SCHEMBL11329310 0.72 KCNN4 (0.56) KCNN4SRCALDH1A1MEN1OPRM1
SCHEMBL4012727 0.72 KCNN4 (0.56) KCNN4SRCALDH1A1MEN1OPRM1
SCHEMBL10881439 0.72 KCNN4 (0.56) KCNN4SRCALDH1A1MEN1OPRM1
SCHEMBL4009225 0.71 KCNN4 (0.55) KCNN4SRCALDH1A1MEN1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781617-A4 ALPHA, BETA-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION JANSSEN PHARMACEUTICA NV (BE) 2009-06-24 EP disclosed
EP-1781617-A2 ALPHA, BETA-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION JANSSEN PHARMACEUTICA N.V. (BE) 2007-05-09 EP disclosed
WO-2006004742-A2 α, β-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION JANSSEN PHARAMCEUTICA N.V. (BE) 2006-01-12 WO disclosed
US-20060004195-A1 Alpha,beta-unsaturated esters and acids by stereoselective dehydration JANSSEN PHARMACEUTICA N.V. (BE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004195-A1 Alpha,beta-unsaturated esters and acids by stereoselective dehydration CCKAR, CCKBR, FFAR1 KCNN4 2499/4885SRC 2380/4885ALDH1A1 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.